A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：BRITISH JOURNAL OF OPHTHALMOLOGY ISSN： 0007-1161 版本： SCI-CDE 出版频率： Monthly 出版社： BMJ PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR   出版社网址： http://bmj.com/index.dtl 期刊网址： http://bjo.bmjjournals.com/ 影响因子： 4.638 主题范畴： OPHTHALMOLOGY 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Fully international, the British Journal of Ophthalmology (BJO) was founded in 1917 by the amalgamation of the Royal London (Moorfields) Ophthalmic Hospital Reports with the Ophthalmoscope and the Ophthalmic Record. Main features include articles on both clinical and laboratory sciences, a series of articles in the form of perspectives, providing brief up to the minute reviews and Commentaries - an occasional series challenging current dogma and opinion. ISSN: 0007-1161 (print version) ISSN: 1468-2079 (electronic version) Publication: Monthly     Instructions to Authors     Instructions for Authors For guidelines on BMJ Journals policy and submission please click on links below. Manuscript formatting Editorial policies Patient consent forms Licence forms Peer review process Online First process Editorial policy British Journal of Ophthalmology is committed to disseminating ongoing advances in ophthalmology across the whole range of sub-specialties and globally. Clearly the requirements of clinicians vary within different settings and in different countries. This is an essential principle that underlies the future planning of the journal and guides the editorial board and reviewers in making their judgements on whether papers submitted to British Journal of Ophthalmology should be accepted or rejected. Our policy is to provide a broad mix of articles that will be of professional and educational value to specialist, visual scientists and trainees. Our priorities are to: Publish up-to-date advances on diagnosis, management and pathogenesis of ocular disease. Continue to develop specialist areas of publication that deal with health service delivery globally. Publish contentious issues that are of educational importance. Ensure that a fair, independent peer review system is in place. Adhere to the highest ethical standards concerning research conduct. Authors should use the American Joint Commission on Cancer classification scheme when describing patients with ophthalmic malignancies; see American Joint Committee on Cancer.ACC Cancer Staging Manual, Seventh Edition, Springer, New York. Open access/unlocked articles Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,700(+VAT)/€2,515(+VAT)/$3,145. Article types and word counts Editorials Original articles Review articles Global issues Innovations Mailbox Education eLetters Supplements The word count excludes the title page, abstract, tables, acknowledgements and contributions and the references. CANCER CLASSIFICATION SCHEME Authors should use the American Joint Commission on Cancer classification scheme when describing patients with ophthalmic malignancies; see American Joint Committee on Cancer. JCC Cancer Staging Manual, Seventh Edition, Springer, New York. Editorials Timely succinct commentary on any aspect of clinical or laboratory ophthalmology, usually in relation to the subject matter of a paper to be published in the same issue. All editorials are commissioned. 1500 words, up to 2 images and tables, 25 references. Original articles Clinical Science: up to 2500 words, 5 images and tables, 25 references Laboratory Science: up to 2500 words, up to 5 images and tables, 25 references Editors may request authors to shorten a submitted manuscript when in the opinion of the Editorial Board, the content does not justify the length. All types of original article should include the following: Title Keywords (up to four) Addresses and which author address for correspondence Structured abstract: (200 words, headings, "Background/aims", "Methods", "Results", and "Conclusion") Introduction Materials and methods Results Discussion References and acknowledgements Legends for display items (Figures and Tables) All original articles are subject to peer review and editorial approval. Review articles Review articles will address any aspect of clinical or laboratory ophthalmology. Most review articles are commissioned but uninvited reviews are also welcome. Prior discussion with the Editor is recommended. Summary: should not exceed 200 words. 2500 - 3000 words, up to 5 images and tables, 50-100 references All review articles are subject to peer review and editorial approval. Global issues Global issues paper emphasise epidemiology and public health issues especially from the underdeveloped countries. Summary: should not exceed 200 words. 2000 words, up to 5 images and tables, 25 references. All global issues articles are subject to peer review and editorial approval. Innovations Manuscripts submitted in this category should describe innovative techniques in any field of ophthalmology including ophthalmic surgery, drugs, optics, and devices. Any relevant preclinical and clinical data should be included. The chief criterion for publication will be the novelty of concepts involved and potential for clinical applications. Summary: should not exceed 200 words. 1000 words, up to 5 images and tables, 25 references. All innovation articles are subject to peer review and editorial approval. Mailbox BJO welcomes short letters to the journal. These may be related to a recent article or series of articles published in the BJO. Original data may be included if it is relevant and gives added weight to the comment on the previously published article. Letters could also include original material that does not merit publication as an original article. Small pilot studies or a small series of cases (3 or more) reporting a novel finding in relation to clinical signs, diagnostic or therapeutic interventions or preliminary experimental data are examples of such material. Word count: up to 600 words. Structured abstract: not required. Tables/Illustrations: up to 2. References: up to 6. Education Manuscripts submitted in this category emphasize clinically relevant management issues that help educate by increasing awareness (how it happened), provide practical guidance for performing common procedures and eliciting clinical signs (how to do it*), practical tips for interpreting test results (how to interpret), and provide simple explanations of how ophthalmic instruments and medications work (how it works). The chief criterion for publication will be educational value of the manuscript. How it happened How to do it How to interpret How it works 1000 words, up to 2 images and tables, 15 references. The manuscript should be divided into three parts (introduction/case report, 3 questions/answers, and discussion). The case report+ should describe exactly how it happened including any errors of judgement in management or diagnosis so that it can be a learning experience to the reader. The questions should be very specific, central to the theme of the report, and their answers form the essential educational component of the manuscript. Discussion should highlight additional related management (How it happened/ How to do it) or technical (How to interpret/How it works) aspects. A sample format can be downloaded here. All educational articles are subject to peer review and editorial approval. *Descriptions of new surgical procedures should be submitted under Original articles - Clinical sciences. +A completed patient consent form for case reports should be provided in all cases. eLetters BJO eLetters are electronic responses to published BJO articles posted online. All eLetters are approved for posting by Dr Robert Bhisitkul, BJO Web Editor. They are not indexed with PubMed, however they maybe selected for inclusion in the journal in the Mailbox section. To submit an eLetter use the submit a response option in the content box menu seen in all abstract/extract, Full text and PDF views of a published article. 300 words, up to 2 images and tables, 5 references All eLetters are subject to editorial approval. Supplements The BMJ Publishing Group journals are willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of: The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement. The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought. The BMJPG itself may have proposals for supplements where sponsorship may be necessary. A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement. In all cases, it is vital that the journal's integrity, independence and academic reputation is not compromised in any way. For further information on criteria that must be fulfilled, download the supplements guidelines (PDF).           Editorial Board Editors Creig S Hoyt University of California San Francisco, CA, USA Email: choyt@itsa.ucsf.edu Andrew D Dick Bristol Eye Hospital Bristol, UK Email:a.dick@bristol.ac.uk Web Editor Robert Bhisitkul Email: bhisit@itsa.ucsf.edu Editorial Assistants USA Office Scott Rostler University of California San Francisco, CA, USA Tel:  +1 415 502 6871  Fax: +1 415 514 1512 Email: choyt@itsa.ucsf.edu UK Office Anne Williams  Division of Ophthalmology  Bristol Eye Hospital  Lower Maudlin Street  Bristol BS1 2LX  Tel: + (0)117 929 4496  Fax: + (0)117 929 4607   Email: anne.williams@bristol.ac.uk Technical Editor Glen Hughes  16 Hyde Vale  Greenwich  London SE10 8QH  Email: ghughes@btinternet.com Managing Editor Andrea Horgan BMJ Journals, BMJPG Ltd BMA House Tavistock Square London, W1T 6JA Email: ahorgan@bmjgroup.com Board Members R Ali Moorfields Eye Hospital, London, England J Alio Inst Oftalmologieo de Alicante, Alicante, Spain A Alm University Hospital, Uppsala, Sweden Ali A Alrajhi King Khaled Eye Spec, PO Box 7191 Al-Oroba St, Riyadh, Saudi Arabia 11462 M Boulton Cardiff University, Cardiff, Wales G Brown Flourtown, PA, USA M Brown Flourtown, PA, USA A Brooks East Melbourne, Victoria, Australia J K Dart Moorfields Eye Hospital, London, England F W Fitzke Moorfields Eye Hospital, London, England J Forrester Inst of Medical Sci Foresterhill, Aberdeen, Scotland W V Good Smith-Kettlewell Eye Research, San Francisco, USA G Holder Moorfields Eye Hospital, London, England S Kashii Kyoto Univ/Grad Sch of Med, Kyoto, Japan P T Khaw Moorfields Eye Hospital, London, England D Lam Hong Kong Eye Hospital, Kowloon, Hong Kong Tom Lietman University of California San Francisco, Box 0944, UCSF, San Francisco, CA 94143-0944 S L Lightman Moorfields Eye Hospital, London, England P McCluskey Campsie, Australia D McLeod Manchester Royal Eye Hospital, Manchester, England A T Moore Moorfields Eye Hospital, London, UK Fumihiko Mori Department of Ophthalmology, Asahikawa Medical College, Midorigaoka Higashi 2-1-1-1, Asahikawa 078-8510, Japan Selim Orgul University Eye Clinic, Mittlere-Strasse 91, Postfach, Basel, CH 4012, Switerland N A Rao Doheny Eye Institute, Los Angeles, CA USA M Repka Johns Hopkins University, Baltimore, MD, USA S Ruit Tilganga Eye Center, Katmandu, Nepal I Schwab University of California at Davis, Sacramento, CA, USA C Souza-Dias Oftalmologista, Sao Paulo, Brazil D Taylor Hospital for Sick Children, London, (UK T Wong  National University of Singapore, Singapore, Singapore